en POLSKI
eISSN: 2084-9834
ISSN: 0034-6233
Reumatologia/Rheumatology
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank


Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications
5/2006
vol. 44
 
Share:
Send email
Share:
abstract:

The incidence of anticardiolipin antibodies in patients with juvenile lupus erythematosus and nervous system involvement

Agnieszka Gazda
,
Anna Maria Romicka

Reumatologia 2006; 44, 5: 251–254
Online publish date: 2006/11/16
View full text Get citation
 
In this study we investigate the relationship between the presence of anticardiolipin antibodies (aCL) and neuropsychiatric manifestations (NPM) in patients with juvenile lupus erythematosus (JSLE). Among 102 patients with JSLE in 37 of them (36.2%) neuropsychiatric manifestations were observed. In that group in 20 patients (54%) elevated levels of aCL (>5 SD) were found. Antiphospholipid syndrome was recognized in 3 cases. The activity, clinical picture of NPM of JSLE were analyzed. A correlation between high levels of aCL and the appearance of NPM was shown in 12 cases (60%), in 7 children (35%) the increase of aCL levels preceded the neurological signs. In the cases with low levels of aCL, NPM may be a result of other than antibody activity. Nervous system involvement occurred more frequently among patients with elevated levels of aCL. The most frequent was IgG type of aCL.
keywords:

juvenile systemic lupus erythematosus, anticardiolipin antibodies, neuropsychiatric manifestation
EVENTS/KONFERENCJE
BOOKS/KSIĄŻKI



Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.